Nuvilex, Inc.'s Medical Marijuana Research May Enhance Its Diabetes Studies
May 29, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 29, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its medical marijuana subsidiary, Medical Marijuana Sciences, Inc., may have just found a way to work side by side in an...
Nuvilex, Inc.'s Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status
May 13, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 13, 2013) - Nuvilex, Inc. (OTCQB: NVLX) COO Dr. Gerald Crabtree is no stranger to late stage clinical trials or dealing with blockbuster therapies for cancer...
Nuvilex, Inc. Shows Success Treating Mammary Tumors Using Cell Encapsulation Technology
May 07, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 7, 2013) - Nuvilex, Inc. (OTCQB: NVLX) should be convincing investors by now that its technology could truly change the face of healthcare. Many know of the...
Nuvilex, Inc. Price Valuation Justifies Investors' Confidence in Biotech
April 25, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 25, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is an international biotechnology firm quietly going about its business in Silver Spring, Maryland. The company is currently...
Nuvilex, Inc. Phase III Clinical Trials in Strong Hands With Dr. Gerald Crabtree
April 01, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Apr 1, 2013) - Nuvilex, Inc. (OTCQB: NVLX) CEO, Dr. Robert Ryan knew exactly what he was doing two years ago when he announced Dr. Gerald Crabtree would be joining his...